(Q37368084)

20 August 2017

A treatment trade-off based decision aid for patients with locally advanced non-small cell lung cancer (English)

1 reference

20 August 2017

1 reference

Michael D. Brundage

1

1 reference

20 August 2017

Deb Feldman-Stewart

2

1 reference

20 August 2017

Peter Dixon

3

1 reference

20 August 2017

Richard Gregg

4

1 reference

20 August 2017

Youssef Youssef

5

1 reference

20 August 2017

Diane Davies

6

1 reference

20 August 2017

William J. MacKillop

7

1 reference

20 August 2017

language of work or name

1 reference

1 March 2000

1 reference

20 August 2017

1 reference

20 August 2017

3

1 reference

20 August 2017

1

1 reference

20 August 2017

55-68

1 reference

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Patients versus surrogates: whose opinion counts on ethics review panels?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Cancer patients' perceptions of their disease and its treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Fallacy of the five-year survival in lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

A new international staging system for lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Utility approach to measuring health-related quality of life

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

How convergence of research paradigms can improve research on diagnostic judgment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: the right chemotherapy works in the right setting.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

On the elicitation of preferences for alternative therapies.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Whose utilities for decision analysis?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

The visual analogue scale for anxiety: a validation study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Test-retest reliabilities of two treatment-preference instruments in measuring utilities.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Does knowledge guide practice? Another look at the management of non-small-cell lung cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Informed consent -- why are its goals imperfectly realized?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5081084

Eliciting preferences for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1369-6513.2000.00083.X

Working hours as a risk factor for acute myocardial infarction in Japan: case-control study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1369-6513.2000.00083.X

Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1369-6513.2000.00083.X

Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

The Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the non-surgical management of lung cancer

1 reference

12 December 2020

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

12 December 2020

Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer

1 reference

12 December 2020

Decision making during serious illness: what role do patients really want to play?

1 reference

12 December 2020

Evaluation standards for patient decision supports

1 reference

12 December 2020

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

12 December 2020

Decision analysis in locally advanced non-small-cell lung cancer: is it useful?

1 reference

12 December 2020

Variations in the management and outcome of non-small cell lung cancer in Ontario

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group

1 reference

12 December 2020

Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia

1 reference

12 December 2020

Lung cancer treatment decisions: patients' desires for participation and information

1 reference

12 December 2020

10.1046/J.1369-6513.2000.00083.X

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

11281912

1 reference